2018
DOI: 10.1007/s00401-018-1852-9
|View full text |Cite
|
Sign up to set email alerts
|

Senataxin mutations elicit motor neuron degeneration phenotypes and yield TDP-43 mislocalization in ALS4 mice and human patients

Abstract: Amyotrophic lateral sclerosis type 4 (ALS4) is a rare, early-onset, autosomal dominant form of ALS, characterized by slow disease progression and sparing of respiratory musculature. Dominant, gain-of-function mutations in the senataxin gene (SETX) cause ALS4, but the mechanistic basis for motor neuron toxicity is unknown. SETX is a RNA-binding protein with a highly conserved helicase domain, but does not possess a low-complexity domain, making it unique among ALS-linked disease proteins. We derived ALS4 mouse … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
50
0
2

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 49 publications
(52 citation statements)
references
References 70 publications
0
50
0
2
Order By: Relevance
“…RanGap1 is normally present around the nuclear membrane (Fig. 5h–i) but is diffused into the nucleus and at times to the cytoplasm [5, 54] (Fig. 5j–k).…”
Section: Resultsmentioning
confidence: 99%
“…RanGap1 is normally present around the nuclear membrane (Fig. 5h–i) but is diffused into the nucleus and at times to the cytoplasm [5, 54] (Fig. 5j–k).…”
Section: Resultsmentioning
confidence: 99%
“…SCAN2 clinical manifestations include progressive cerebellar atrophy, ataxia, and sensorimotor peripheral neuropathy [169][170][171][172][173]. In contrast, ALS4 mainly affects the motor neurons and the spinal cord, leading to muscle dysfunction [174][175][176].…”
Section: Senataxin Spinocerebellar Ataxia With Axonal Neuropathymentioning
confidence: 99%
“…In another study, cytosolic mislocalization of the transactive response DNAbinding protein (TDP-43) was observed in spinal cord motor neurons in postmortem tissues from all the ALS4 patients examined [8]. TDP-43 is an RNA metabolism factor and is a well-documented biomarker that forms toxic protein aggregates in multiple neurodegenerative diseases including ALS [9,10].…”
Section: Introductionmentioning
confidence: 99%
“…TDP-43 is an RNA metabolism factor and is a well-documented biomarker that forms toxic protein aggregates in multiple neurodegenerative diseases including ALS [9,10]. Recapitulation of TDP-43 histopathology in motor neurons of mice carrying ALS4 mutations led the authors to imply that dysfunction of SETX converges on TDP-43 pathology causing an ALStype motor neurodegeneration [8], although the mechanism was not identified.…”
Section: Introductionmentioning
confidence: 99%